Hypoxia‐related THBD + macrophages as a prognostic factor in glioma: Construction of a powerful risk model
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Weichun Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Blood Transfusion Department, The Third People's Hospital of Bengbu, Bengbu, China. Hauptthemen laut MEDLINE: Macrophages, Glioma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science Research Project of Bengbu Medical College.
Abstract (Originalsprache)
Glioma is a prevalent malignant tumour characterized by hypoxia as a pivotal factor in its progression. This study aims to investigate the impact of the most severely hypoxic cell subpopulation in glioma. Our findings reveal that the THBD + macrophage subpopulation is closely associated with hypoxia in glioma, exhibiting significantly higher infiltration in tumours compared to non‐tumour tissues. Moreover, a high proportion of THBD + cells correlates with poor prognosis in glioblastoma (GBM) patients. Notably, THBD + macrophages exhibit hypoxic characteristics and epithelial‐mesenchymal transition features. Silencing THBD expression leads to a notable reduction in the proliferation and metastasis of glioma cells. Furthermore, we developed a THBD + macrophage‐related risk signature (THBDMRS) through machine learning techniques. THBDMRS emerges as an independent prognostic factor for GBM patients with a substantial prognostic impact. By comparing THBDMRS with 119 established prognostic features, we demonstrate the superior prognostic performance of THBDMRS. Additionally, THBDMRS is associated with glioma metastasis and extracellular matrix remodelling. In conclusion, hypoxia‐related THBD + macrophages play a pivotal role in glioma pathogenesis, and THBDMRS emerges as a potent and promising prognostic tool for GBM, contributing to enhanced patient survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blood Transfusion Department, The Third People's Hospital of Bengbu, Bengbu, China.
- Department of Rehabilitation Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
- Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, China.
- Medical School of Southeast University, Nanjing, China.
- School of Medical Technology, Xinxiang Medical University, Xinxiang, China.
ORCID-Profile: Mengtong Xue, Linlin Zhu
Förderung
- the Science Research Project of Bengbu Medical College
Zitieren
APA
Tang, W., Du, J., Li, L., Hu, S., Ma, S., Xue, M., & Zhu, L. (2024). Hypoxia‐related THBD + macrophages as a prognostic factor in glioma: Construction of a powerful risk model. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18393
Vancouver
Tang W, Du J, Li L, Hu S, Ma S, Xue M, et al. Hypoxia‐related THBD + macrophages as a prognostic factor in glioma: Construction of a powerful risk model. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18393
BibTeX
@article{Tang2024,
author = {Tang, Weichun and Du, Juntao and Li, Lin and Hu, Shangshang and Ma, Shuo and Xue, Mengtong and Zhu, Linlin},
title = {Hypoxia‐related THBD + macrophages as a prognostic factor in glioma: Construction of a powerful risk model},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18393}
}
EUVIMED